The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.50
Bid: 70.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 15.00 (21.429%)
Open: 77.50
High: 77.50
Low: 77.50
Prev. Close: 77.50
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

22 Apr 2020 07:00

RNS Number : 4131K
Biome Technologies PLC
22 April 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR")

 

22 April 2020

 

 

Biome Technologies plc

 

("Biome", "the Company" or "the Group")

 

Trading Update

 

 

 

The Annual General Meeting ("AGM") of Biome Technologies, a leading bioplastics and radio frequency technology business, was due to be held today. Whilst the AGM has been delayed due to Covid-19, the Board is pleased to announce the Company's customary trading update for the three months ended 31 March 2020.

 

Group revenues achieved for the first three months of the year were £1.3m (Q1 2019: £2.1m), reflecting a very strong revenue performance from the Bioplastics division and subdued demand in the Stanelco RF division.

 

The impact of Covid-19 on Biome during the first quarter of 2020 was limited, with trading in the quarter being in line with management's expectations at the time of the Group's trading update on 30 January 2020. The Group continues its manufacturing and development operations with the upmost consideration for the safety of its staff and in conformance with Government advice.

 

The Group remained debt free as at 31 March 2020 and had cash of £1.8m (31 December 2019: £2.1m) and had cash of £1.7m as at 14 April 2020 and no debt.

 

Bioplastics Division

 

Revenues in the Bioplastics division of £1.1m were up 83% on the same period last year and matched the record quarterly revenues of Q4 2019 (Q1 2019: £0.6m; Q4 2019: £1.1m). The performance in the period was underpinned by increased sales of outer packaging for the US single serve coffee market and by growing revenues for rigid ring materials for the coffee-pod market. There is growing evidence that the ordering of coffee products for home delivery was supporting demand towards the end of the quarter. Progress on other projects, such as the nutraceutical pod, was more limited as Covid-19 began to impact some customers' developmental activities. For others, developmental work continues with some vigour and the business is well positioned to exploit various opportunities in this growing market as and when conditions allow.

 

Stanelco RF Technologies Division

 

Revenues for the first quarter of 2020 in the Stanelco RF division were £0.2m (Q1 2019: £1.5m). The Stanelco RF division's principal revenues are derived from the production and maintenance of furnaces for the manufacture of fibre optical cable. Market intelligence currently indicates that there is over capacity in the fibre optic cable market. This market position is now exacerbated by the effect of Covid-19 on sentiment towards purchases of capital goods. It is unlikely that this position will change quickly and the Group's expectations are already set accordingly. The Board expects demand for fibre optic cable for internet capacity and 5G implementation to recover in due course. At present the division's sales activities are focused on alternative industrial markets in the UK/Europe which the Board believes will support increased revenues in the second half of 2020.

 

Other matters

 

In Biome's announcement on 25 March 2020, it was stated that the Company's AGM had been deferred to a date in June 2020 due to the Covid-19 crisis. A further announcement will be made when the precise date when the AGM will be held can be confirmed.

 

Outlook

 

The Group's trading continues in line with the expectations set out in the Company's Final Result's announcement released on 16 April 2020.

 

The Final Results announcement also outlined the range of actions the Board is taking as a result of Covid-19. The focus of these actions is to maximise Biome's commercial opportunities whilst managing the Group's cost base and cash resources with the aim of delivering good medium-term growth for shareholders.

 

 

 

 

- Ends -

 

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

David Hughes, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and that are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

 

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited. Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers. Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets

 

www.biometechnologiesplc.com

www.biomebioplastics.com and www.thinkbioplastic.com 

www.stanelcorftechnologies.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKDBBOBKDKQB
Date   Source Headline
1st Aug 20057:01 amRNSDirector Appointment
28th Jul 20057:01 amRNSUpdate re: trials with ASDA
26th Jul 20057:00 amRNSContract Win
19th Jul 20057:00 amRNSRe Agreement
5th Jul 20057:01 amRNSRe Joint Venture
29th Jun 20057:00 amRNSInterim Results
22nd Jun 20057:00 amRNSUpdate re trials with Asda
8th Jun 20055:29 pmRNSAdditional Listing
8th Jun 200510:00 amRNSAppointment of Group MD
8th Jun 20057:50 amRNSPlacing of Ordinary Shares
6th Jun 20057:01 amRNSAcquisition
3rd Jun 20053:02 pmRNSIssue of Equity
23rd May 20057:01 amRNSRe Contract
17th May 200512:12 pmRNSAdditional Listing
10th May 20057:00 amRNSUpdate re. trials with Asda
29th Apr 20053:46 pmRNSHolding(s) in Company
25th Apr 20053:27 pmRNSDirector Shareholding
22nd Apr 20052:24 pmRNSResult of AGM
22nd Apr 200511:31 amRNSAGM Statement
11th Apr 20057:00 amRNSRe Agreement
7th Apr 20057:00 amRNSRe Agreement
6th Apr 200512:41 pmRNSAdditional Listing
24th Mar 20057:00 amRNSRe Contract
22nd Mar 20054:49 pmRNSAnnual Report and Accounts
21st Mar 20057:02 amRNSStatement on High Court
1st Mar 20057:01 amRNSUpdate re. trials with Asda
28th Feb 20057:00 amRNSFinal Results
23rd Feb 20054:45 pmRNSAdditional Listing
9th Feb 20053:16 pmRNSAgreement and Placing
8th Feb 20057:00 amRNSUpdate re. trials with Asda
31st Jan 20059:09 amRNSRe. Agreement
25th Jan 20057:00 amRNSDirectorate Change
17th Jan 200511:44 amRNSAdditional Listing
4th Jan 200511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.